Regeneron and TriNetX forge $200M partnership to supercharge drug discovery and digital health
TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
The center brings together hands on technology demonstrations, application expertise, and commercial operations
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The trial met its primary endpoint, with the combination therapy demonstrating a “statistically significant and clinically meaningful” improvement in radiographic progression-free survival
The study hit its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) compared to placebo plus XTANDI
The new solution combines Watchmaker Genomics’ high-performance NGS chemistry with Volta’s digital fluidics platform
Hologic has been at the forefront of cervical cancer screening for decades
Subscribe To Our Newsletter & Stay Updated